Development of antivirals against influenza

Expert Opinion on Investigational Drugs

Volumn 7, Issue 2, 1998, Pages 149-165

  Cianci, C ^a   Krystal, M ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

Amantadine; Antivirals; GG 167; GS 4071; GS 4104; Influenza; M2; Neuraminidase; Rimantadine; Zanamivir

Indexed keywords

4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; ADAMANTANE DERIVATIVE; AMANTADINE; ANTIVIRUS AGENT; HEMAGGLUTININ; INFLUENZA VACCINE; OSELTAMIVIR; RIBAVIRIN; RIMANTADINE; SIALIDASE; SIALIDASE INHIBITOR; UNCLASSIFIED DRUG; ZANAMIVIR;

DRUG DEVELOPMENT; DRUG EFFICACY; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; INFLUENZA VIRUS A; PROPHYLAXIS; REVIEW;

EID: 0031964485     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.7.2.149     Document Type: Review

References (163)